Trastuzumab and chemotherapy improved survival in HER2-postive breast and brain cancer patients

Monday, July 18, 2011 - 03:00 in Health & Medicine

The use of trastuzumab, chemotherapy and surgery among women with HER2-positive metastatic breast cancer significantly improved survival from the time central nervous system metastases were diagnosed.

Read the whole article on Physorg

More from Physorg

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net